AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ROXITHROMYCIN
14 registrations across 4 African markets— 7 active
Markets with ROXITHROMYCIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Roxysaf Tablet Roxithromycin 150 mg Tablet | 🇳🇬Nigeria | Nurushat Ventures Limited | active | Jul 2028 |
| CIPLA-ROXITHROMYCIN 150 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ROXXIBID 150 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| THROSYN 150 mg TABLET | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| ROXIGEN | 🇿🇦South Africa | MERCK GENERICS RSA (PTY) LTD | suspended | Nov 2022 |
| ROXID-150 150MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2010 |
| ROXID-300 300MG TABLET TABLET | 🇲🇼Malawi | — | expired | Aug 2004 |
| ROXID 50MG/5ML ORAL SUSPENSION ORAL SUSPENSION | 🇲🇼Malawi | — | expired | Aug 2004 |
| ROXITHROMYCIN - HEXAL 150 | 🇿🇦South Africa | HEXAL PHARMA (SA) (PTY) LTD | active | Jan 1900 |
| ROXITHROMYCIN - HEXAL 300 | 🇿🇦South Africa | HEXAL PHARMA (SA) (PTY) LTD | active | Jan 1900 |
| ROXITHROMYCIN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | BRAWN LABORATORIES LTD | active | — |
| ROXITHROMYCIN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | BRAWN LABORATORIES LTD | active | — |
| ROXITHROMYCIN ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | BRAWN LABORATORIES LTD | active | — |
| ROXITHROMYCIN ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | BRAWN LABORATORIES LTD | active | — |
ROXITHROMYCIN in Africa — Regulatory Overview
ROXITHROMYCIN is registered across 4 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Malawi, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 14 registrations, 7 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.